One of the biggest appeals of the Fantasy genre lies in the things that can exist in these worlds, from dragons to whirls of ...

NEW YORK — Akero Ther­a­peu­tics may not have ad­e­quate da­ta for ac­cel­er­at­ed ap­proval of its MASH drug, de­spite show­ing it may re­verse cir­rho­sis in pa­tients with … ...

Mark Zuckerberg, Sheryl Sandberg, and other Meta veterans have reason to fear this tell-all from a former employee. Here's why.

Prince Charming, a small role in the cartoon, gets the hook ... But don’t worry, the movie is not so 2025 that Snow White’s revived by true love’s handshake. The worst thing about ...

MASH VP! Re:VISION is a revolutionary rhythm game that “fuses” two lines and music into a completely new experience. With a variety of tracks, game modes, and a creativity-driven mashup system ...

One of London’s last remaining pie and mash shops is set to close at the end of month after 116 years of serving customers. Harrington’s Eel and Pie House in Tooting will shut for good on ...

With its creepy CGI dwarfs and muddled tone, Disney's latest live-action remake is "not calamitous" but is a "a mind-boggling mash-up ... Singin' in the Rain as a cartoon. Another issue is ...

Similarly, the first half of “Mermaid” isn’t played for suspense at all, despite its central monster ... cameo to kill off in the cold open of a movie. Robert Patrick and Kevin Dunn make ...

The smalltime distribution company seemingly had a modest marketing budget for the new film, as the movie has only done a little over $3 million at the box office for opening weekend on over 2,800 ...

Ponman OTT release: Ponman is a Malayalam dark comedy action movie based on GR Indugopan's novel Naalanchu Cheruppakar. Directed by Jothish Shankar, Ponman was released in theatres on January 30.

Statistically, you probably haven’t seen the Monster Hunter movie, probably because it came out at exactly the wrong time. Paul W.S. Anderson’s adaptation of Capcom’s video game series was ...

The once-fledg­ling field of MASH drug de­vel­op­ers is now one of the few ar­eas of con­sis­ten­cy in the biotech in­dus­try.